Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 33


Apolipoprotein A-IV enhances cholecystokinnin secretion.

Zhan J, Weng J, Hunt BG, Sean Davidson W, Liu M, Lo CC.

Physiol Behav. 2018 May 1;188:11-17. doi: 10.1016/j.physbeh.2018.01.019. Epub 2018 Jan 31.


Energy homeostasis in apolipoprotein AIV and cholecystokinin-deficient mice.

Weng J, Lou D, Benoit SC, Coschigano N, Woods SC, Tso P, Lo CC.

Am J Physiol Regul Integr Comp Physiol. 2017 Nov 1;313(5):R535-R548. doi: 10.1152/ajpregu.00034.2017. Epub 2017 Aug 2.


Antibiotics Suppress Activation of Intestinal Mucosal Mast Cells and Reduce Dietary Lipid Absorption in Sprague-Dawley Rats.

Sato H, Zhang LS, Martinez K, Chang EB, Yang Q, Wang F, Howles PN, Hokari R, Miura S, Tso P.

Gastroenterology. 2016 Nov;151(5):923-932. doi: 10.1053/j.gastro.2016.07.009. Epub 2016 Jul 18.


Apolipoprotein A-V is present in bile and its secretion increases with lipid absorption in Sprague-Dawley rats.

Zhang LS, Sato H, Yang Q, Ryan RO, Wang DQ, Howles PN, Tso P.

Am J Physiol Gastrointest Liver Physiol. 2015 Dec 1;309(11):G918-25. doi: 10.1152/ajpgi.00227.2015. Epub 2015 Oct 1.


Lipid transport in cholecystokinin knockout mice.

King A, Yang Q, Huesman S, Rider T, Lo CC.

Physiol Behav. 2015 Nov 1;151:198-206. doi: 10.1016/j.physbeh.2015.07.009. Epub 2015 Jul 11.


The pathophysiology of intestinal lipoprotein production.

Giammanco A, Cefal├╣ AB, Noto D, Averna MR.

Front Physiol. 2015 Mar 20;6:61. doi: 10.3389/fphys.2015.00061. eCollection 2015. Review.


Lipid-induced insulin resistance does not impair insulin access to skeletal muscle.

Kolka CM, Richey JM, Castro AV, Broussard JL, Ionut V, Bergman RN.

Am J Physiol Endocrinol Metab. 2015 Jun 1;308(11):E1001-9. doi: 10.1152/ajpendo.00015.2015. Epub 2015 Apr 7.


Apolipoprotein A-IV: a protein intimately involved in metabolism.

Wang F, Kohan AB, Lo CM, Liu M, Howles P, Tso P.

J Lipid Res. 2015 Aug;56(8):1403-18. doi: 10.1194/jlr.R052753. Epub 2015 Feb 1. Review.


Zebrafish as a model for apolipoprotein biology: comprehensive expression analysis and a role for ApoA-IV in regulating food intake.

Otis JP, Zeituni EM, Thierer JH, Anderson JL, Brown AC, Boehm ED, Cerchione DM, Ceasrine AM, Avraham-Davidi I, Tempelhof H, Yaniv K, Farber SA.

Dis Model Mech. 2015 Mar;8(3):295-309. doi: 10.1242/dmm.018754. Epub 2015 Jan 29.


Apolipoprotein A-V deficiency enhances chylomicron production in lymph fistula mice.

Zhang LS, Xu M, Yang Q, Ryan RO, Howles P, Tso P.

Am J Physiol Gastrointest Liver Physiol. 2015 Apr 1;308(7):G634-42. doi: 10.1152/ajpgi.00339.2014. Epub 2015 Jan 23.


ApoA-IV: current and emerging roles in intestinal lipid metabolism, glucose homeostasis, and satiety.

Kohan AB, Wang F, Lo CM, Liu M, Tso P.

Am J Physiol Gastrointest Liver Physiol. 2015 Mar 15;308(6):G472-81. doi: 10.1152/ajpgi.00098.2014. Epub 2015 Jan 15. Review.


Intraperitoneal CCK and fourth-intraventricular Apo AIV require both peripheral and NTS CCK1R to reduce food intake in male rats.

Lo CC, Davidson WS, Hibbard SK, Georgievsky M, Lee A, Tso P, Woods SC.

Endocrinology. 2014 May;155(5):1700-7. doi: 10.1210/en.2013-1846. Epub 2014 Feb 24.


The structure of human apolipoprotein A-IV as revealed by stable isotope-assisted cross-linking, molecular dynamics, and small angle x-ray scattering.

Walker RG, Deng X, Melchior JT, Morris J, Tso P, Jones MK, Segrest JP, Thompson TB, Davidson WS.

J Biol Chem. 2014 Feb 28;289(9):5596-608. doi: 10.1074/jbc.M113.541037. Epub 2014 Jan 14.


Specific sequences in N termini of apolipoprotein A-IV modulate its anorectic effect.

Wang F, Pearson KJ, Davidson WS, Tso P.

Physiol Behav. 2013 Aug 15;120:136-42. doi: 10.1016/j.physbeh.2013.07.010. Epub 2013 Jul 30.


Serum immune-related proteins are differentially expressed during hibernation in the American black bear.

Chow BA, Donahue SW, Vaughan MR, McConkey B, Vijayan MM.

PLoS One. 2013 Jun 25;8(6):e66119. doi: 10.1371/journal.pone.0066119. Print 2013.


Is apolipoprotein A-IV rate limiting in the intestinal transport and absorption of triglyceride?

Kohan AB, Wang F, Li X, Vandersall AE, Huesman S, Xu M, Yang Q, Lou D, Tso P.

Am J Physiol Gastrointest Liver Physiol. 2013 Jun 15;304(12):G1128-35. doi: 10.1152/ajpgi.00409.2012. Epub 2013 Apr 18.


Apolipoprotein AIV requires cholecystokinin and vagal nerves to suppress food intake.

Lo CC, Langhans W, Georgievsky M, Arnold M, Caldwell JL, Cheng S, Liu M, Woods SC, Tso P.

Endocrinology. 2012 Dec;153(12):5857-65. doi: 10.1210/en.2012-1427. Epub 2012 Oct 1.


Chylomicron formation and secretion is required for lipid-stimulated release of incretins GLP-1 and GIP.

Lu WJ, Yang Q, Yang L, Lee D, D'Alessio D, Tso P.

Lipids. 2012 Jun;47(6):571-80. doi: 10.1007/s11745-011-3650-1.


ApoA-IV modulates the secretory trafficking of apoB and the size of triglyceride-rich lipoproteins.

Weinberg RB, Gallagher JW, Fabritius MA, Shelness GS.

J Lipid Res. 2012 Apr;53(4):736-43. doi: 10.1194/jlr.M019992. Epub 2012 Jan 18.


Apolipoprotein A-IV regulates chylomicron metabolism-mechanism and function.

Kohan AB, Wang F, Li X, Bradshaw S, Yang Q, Caldwell JL, Bullock TM, Tso P.

Am J Physiol Gastrointest Liver Physiol. 2012 Mar 15;302(6):G628-36. doi: 10.1152/ajpgi.00225.2011. Epub 2011 Dec 29.

Supplemental Content

Support Center